Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.6K
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2026 ESAIC Consensus Document on Mitigation Strategies in Intensive Care Medicine: Consensus document of the European Society of Anaesthesiology and Intensive Care.

European journal of anaesthesiology·2026
Same author

Correction: The effects of music and virtual reality on pain and anxiety during central venous port implantation: a randomised clinical trial.

Scientific reports·2026
Same author

Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy.

International journal of molecular sciences·2026
Same author

ITPP in early pancreatic zebrafish xenografts mildly impacts tumor cell death without interfering with vascular normalization.

BMC cancer·2026
Same author

The transmembrane IL-15 isoform expressed on human melanoma cells triggers modulatory effects on tumor progression upon stimulation with the soluble IL-15Rα chain.

Frontiers in immunology·2026
Same author

The effects of music and virtual reality on pain and anxiety during central venous port implantation: a randomised clinical trial.

Scientific reports·2026

Related Experiment Video

Updated: Apr 21, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment.

Muhammad Zaeem Noman1, Yosra Messai, Jane Muret

  • 1INSERM U753, Gustave Roussy Cancer campus, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|October 23, 2014
PubMed
Summary

Hypoxia promotes tumor progression by inducing circulating tumor cells (CTCs) and cancer stem cells (CSCs) with enhanced survival and immune evasion. Targeting hypoxic pathways may offer new immunotherapy strategies against metastasis.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.0K

Related Experiment Videos

Last Updated: Apr 21, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.0K

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Tumor microenvironment, particularly hypoxia, significantly influences cancer cell behavior.
  • Circulating tumor cells (CTCs) and cancer stem cells (CSCs) are critical for metastasis and disease recurrence.
  • Hypoxia is implicated in the emergence and survival of CTCs and CSCs, contributing to treatment resistance.

Purpose of the Study:

  • To explore the role of hypoxia in regulating tumor progression, epithelial-mesenchymal transition (EMT), and CSC phenotypes.
  • To elucidate the relationship between hypoxia and CTCs, including their interaction with the immune system.
  • To investigate the potential of targeting hypoxic signaling pathways for cancer immunotherapy.

Main Methods:

  • Review of existing literature on hypoxia, CTCs, CSCs, EMT, and immune evasion.
  • Analysis of the interplay between hypoxic stress, cellular phenotypes, and immune responses.
  • Discussion of potential therapeutic strategies targeting hypoxic signaling.

Main Results:

  • Hypoxia drives tumor progression by inducing EMT and CSC-like features in tumor cells.
  • Hypoxia contributes to the survival and immune evasion of CTCs.
  • Hypoxic stress confers resistance to CTCs, enhancing their metastatic potential.

Conclusions:

  • Hypoxia plays a crucial role in promoting tumor progression, metastasis, and immune evasion through the induction of CTCs and CSCs.
  • Understanding the mechanisms of hypoxic stress on CTCs and their interaction with the immune system is vital for developing effective immunotherapies.
  • Inhibition of hypoxic signaling pathways presents a promising therapeutic avenue to reduce CTCs, overcome resistance, and enhance immune-mediated tumor cell lysis.